Star Super Speciality Medi Cure Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-05-2024
- Paid Up Capital ₹ 0.40 M
as on 18-05-2024
- Company Age 14 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Profit -45.53%
(FY 2019)
- Ebitda -41.97%
(FY 2019)
- Net Worth -9.32%
(FY 2019)
- Total Assets -5.13%
(FY 2019)
About Star Super Speciality Medi Cure
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Taneja, Ashu Mithal, Adesh Dhankad, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191UP2010PTC042856
- Company No.
042856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Star Super Speciality Medi Cure?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Taneja  | Director | 23-Jan-2017 | Current |
| Ashu Mithal | Director | 09-Jun-2018 | Current |
| Adesh Dhankad | Director | 09-Jun-2018 | Current |
| Rajeev Jain | Director | 22-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Star Super Speciality Medi Cure.
Star Super Speciality Medi Cure Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 45.53% decrease in profit. The company's net worth dipped by a decrease of 9.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Star Super Speciality Medi Cure?
In 2017, Star Super Speciality Medi Cure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Narayan Medicare Private LimitedActive 20 years 7 monthsAnil Taneja and Adesh Dhankad are mutual person
- Aim Infraheights Private LimitedActive 14 years 8 months
Ashu Mithal and Adesh Dhankad are mutual person
- Ams Infranirman Private LimitedActive 11 years 5 months
Ashu Mithal and Adesh Dhankad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Star Super Speciality Medi Cure?
Unlock and access historical data on people associated with Star Super Speciality Medi Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Star Super Speciality Medi Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Star Super Speciality Medi Cure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
